CT Colonography for Colorectal Cancer Screening: Research Update
CT Colonography: A Viable,Non-Invasive Alternative for Colorectal Cancer Screening
Table of Contents
New research highlights the enduring accuracy and safety of CT colonography (CTC) as a colorectal cancer (CRC) screening tool,even amidst declining utilization.
Three Key Takeaways
High predictive accuracy for polyps. CTC demonstrated a 91.6 percent positive predictive value (PPV) for polyps ≥ 6 mm, with particularly strong performance for identifying sessile (94.1 percent PPV) and pedunculated polyps (95.7 percent PPV), affirming its diagnostic accuracy compared to optical colonoscopy (OC).
Non-invasive and low-risk screening option. CTC proved to be a safe, non-invasive screening method with no major complications or colonic perforations reported. It also allowed detection of clinically relevant extracolonic findings, such as advanced adenomas (4 percent), extracolonic malignancies (0.4 percent), and abdominal aortic aneurysms (0.3 percent).
* Viable CRC screening alternative despite declining use. Even though CTC utilization for primary CRC screening declined sharply (from 1,589 exams in 2005 to 72 in 2023) at the study facility, the study supports its continued role as a viable CRC screening alternative, especially with recent Medicare coverage determinations for CTC.
Enduring Accuracy and Safety
despite a significant drop in its use for primary asymptomatic screening-from 1,589 exams in 2005 to just 72 in 2023 at the study facility-CT colonography (CTC) continues to be a highly accurate and safe method for colorectal cancer (CRC) detection.Researchers emphasize that recent developments, including new Medicare coverage decisions for CTC, reinforce its position as a valuable screening option.The study underscores CTC’s impressive diagnostic capabilities, particularly its high positive predictive value (PPV) of 91.6 percent for polyps measuring 6 mm or larger. Its performance was especially robust in identifying specific polyp types: sessile polyps achieved a 94.1 percent PPV, while pedunculated polyps reached a 95.7 percent PPV. These figures affirm CTC’s diagnostic precision when benchmarked against optical colonoscopy (OC).
Beyond Colorectal Screening: Extracolonic Benefits
A significant advantage of CTC lies in its non-invasive nature and low risk profile.The screening method reported no major complications or colonic perforations, offering a safer alternative for patients who may be hesitant about or medically unsuitable for invasive procedures like traditional colonoscopy.
Furthermore, CTC provides the unique benefit of detecting clinically relevant extracolonic findings. The study identified advanced adenomas in 4 percent of patients, extracolonic malignancies in 0.4 percent, and abdominal aortic aneurysms in 0.3 percent. These incidental findings can lead to earlier diagnosis and treatment of other serious health conditions, adding substantial value to the screening process.
A Resilient Screening Modality
“Through proper technique, CTC screening can provide noninvasive CRC prevention that is lacking with stool-based tests, avoid the complications associated with primary OC screening, and provide the unique additional benefit of extracolonic evaluation,” stated the study’s authors, Pickhardt and colleagues. This comprehensive approach positions CTC as a compelling choice for CRC screening, offering a blend of accuracy, safety, and broader health insights.
While acknowledging the limitations of a single-center retrospective study, including the lack of systematic documentation for missed colorectal lesions and variations in radiologist performance, the researchers remain confident in CTC’s continued relevance.The recent national coverage determination for CTC screening of Medicare beneficiaries further bolsters its accessibility and viability as a crucial tool in the ongoing fight against colorectal cancer.
For further insights into the evolving landscape of CRC screening, readers may find related content on CT colonography’s higher reduction in CRC incidence compared to Cologuard, its integration into radiology practices, and its increased utilization during the COVID-19 pandemic informative.